Point72 Asia (Singapore) Pte. Ltd. Health Catalyst, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $480 Billion
- Q2 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 2,380 shares of HCAT stock, worth $18,326. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,380
Previous 16,785
85.82%
Holding current value
$18,326
Previous $126 Million
87.97%
% of portfolio
0.0%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding HCAT
# of Institutions
167Shares Held
48.7MCall Options Held
2.51MPut Options Held
1.8K-
Black Rock Inc. New York, NY5.43MShares$41.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.53MShares$34.9 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN3.96MShares$30.5 Million2.3% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.41MShares$18.6 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA2.38MShares$18.3 Million0.01% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $421M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...